C21 Investments Inc. (CNQ: CXXI) Stock Analysis & Fundamentals

CXXIC21 Investments Inc.

CNQ · CA · Healthcare · Drug Manufacturers - Specialty & Generic · cxxi.ca

0.2900CAD0.00%Mkt Cap: 25.06M $P/E: —22d ago

C21 Investments Inc., an integrated cannabis company, cultivates, processes, distributes, and sells cannabis and hemp-derived consumer products in the United States. The company offers CO2, live resin, distillate, CBD cu…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.24BUSDP/E 23.7

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

$15.39BUSDP/E 118.0

NBIX

Neurocrine Biosciences, Inc.

Elanco Animal Health Incorporat

Hims & Hers Health, Inc.

Lantheus Holdings Inc

$6.56BUSDP/E 24.0

AMRX

Amneal Pharmaceuticals, Inc.

$6.23BUSDP/E 37.3

INDV

Indivior PLC Ordinary Shares

$4.61BUSDP/E 14.0

HIK

Hikma Pharmaceuticals PLC

$4.32BUSDP/E 12.5

AMLX

Amylyx Pharmaceuticals Inc. Common Stock

Laboratorios Farmaceuticos Rovi, S.A.

$3.34BUSDP/E 16.6

SUPN

Supernus Pharmaceuticals, Inc.

$2.82BUSD

Key Statistics

Company

Market Cap25.06M $

Enterprise Value39.30M $

Revenue (TTM)23.75M $

Gross Profit9.91M $

Net Income (TTM)-2.36M $

Revenue/Share0.2017 USD

Last Price0.2900 CAD

Fiscal Year EndMar 2026

MR QuarterMar 2026

Employees—

CountryCA

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA15.07

EV/Revenue1.65

P/S1.40

P/B1.28

EPS (TTM)-0.04

EPS (Forward)—

52W Range

0.26506% of range0.6800

52W High0.6800 CAD

52W Low0.2650 CAD

Profitability

Gross Margin41.71%

Oper. Margin6.59%

EBITDA Margin10.98%

Profit Margin-9.95%

ROE-12.75%

ROA-5.96%

Growth

Revenue Growth-8.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF986.84K $

CapEx (TTM)178.31K $

FCF Margin5.48%

FCF Yield5.19%

Net Debt6.02M $

Net Debt/EBITDA2.31

Balance Sheet

Debt/Equity0.41

Current Ratio1.30

Quick Ratio0.36

Book Value/Sh0.2996 CAD

Cash/Share0.0190 CAD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 CAD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateMay 12, 2017

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.118.68M

Float104.35M

Insiders12.32%

Institutions5.51%

Short Interest

Short Ratio1.5d

Short % Float0.09%

Short % Out.0.08%

Shares Short97.27K

Short (prev mo.)6.52K

Technical

SMA 500.3399 (-14.7%)

SMA 2000.3998 (-27.5%)

Beta1.88

S&P 52W Chg18.16%

Avg Vol (30d)53.10K

Avg Vol (10d)79.92K

Technical Indicators

RSI (14)39.9

MACD-0.0181

MACD Signal-0.0161

MACD Hist.-0.0020

BB Upper0.3683 CAD

BB Middle0.3177 CAD

BB Lower0.2672 CAD

BB Width31.80%

ATR (14)0.0202 CAD

Vol Ratio (20d)1.10x